Abstract
Transcatheter aortic valve implantation (TAVI) was created for treating high-group risk patients for cardiac
bypass surgery. The method is successfully used in patients of this group, and according to the results of major
research significantly increases life expectancy. However, patients of this group often have complications
after TAVI due to irreversible changes in myocardium and gross deformation in native valve. Periprosthetic
regurgitation is the most common complication, the degree of which affects life expectancy. The approach
for correction such condition is unclear. In this review, we present the approach of one-stage correction
of periprostetic regurgitation and aneurysmal expansion of the ascending aorta after TAVI.
References
-
Cribier A., Eltchaninoff H., Bash A., Borenstein N.,
Tron C., Bauer F. et al. Percutaneous transcatheter
implantation of an aortic valve prosthesis for calcific
aortic stenosis: first human case description.
Circulation. 2002; 106 (24): 3006–8. DOI: 10.1161/01.CIR.0000047200.36165.B8
- Otto C.M., Kumbhani D.J., Alexander K.P., Calhoon
J.H., Desai M.Y., Kaul S. et al. 2017 ACC Expert
Consensus Decision Pathway for Transcatheter Aortic
Valve Replacement in the Management of Adults with
Aortic Stenosis. A report of the American College of
Cardiology Task Force on Clinical Expert Consensus
Documents. JACC. 2017; 69 (10): 37339–9. DOI:10.1016/j.jacc.2016.12.006
- Vahanian A., Alfieri O., Andreotti F., Antunes M.J.,
Barón-Esquivias G., Baumgartner H. et al. Joint Task
Force on the Management of Valvular Heart Disease of
the European Society of Cardiology (ESC); European
Association for Cardio-Thoracic Surgery (EACTS).
Guidelines on the management of valvular heart disease
(version 2012). Eur. Heart J. 2012; 33 (19): 2451–96.
DOI: 10.1093/eurheartj/ehs109
- Nishimura R.A., Otto C.M., Bonow R.O., Carabello
B.A., Erwin J.P. 3rd, Guyton R.A. et al. American
College of Cardiology/American Heart Association
Task Force on Practice Guidelines. 2014 AHA/ACC
guideline for the management of patients with valvular
heart disease: executive summary: a report of the
American College of Cardiology/American Heart
Association Task Force on Practice Guidelines. J. Am.
Coll. Cardiol. 2014; 63 (22): 2438–88. DOI: 10.1016/j.jacc.2014.02.536
- Gargiulo G., Sannino A., Capodanno D., Barbanti M.,
Buccheri S., Perrino C. et al. Transcatheter aortic
valve implantation versus surgical aortic valve replacement:
A systematic review and meta-analysis. Ann.
Intern. Med. 2016; 165 (5): 334–44. DOI: 10.7326/M16-0060
- Koifman E., Didier R., Garcia-Garcia H., Weissman
G., Ertel A.W., Kiramijyan S. et al. Management
and outcome of residual aortic regurgitation after transcatheter
aortic valve implantation. Am. J. Cardiol.
2017; 0002-9149 (17): 30869-X. DOI: 10.1016/j.amjcard.2017.05.033
- Lindman B.R., Maniar H.S., Jaber W.A., Lerakis S.,
Mack M.J., Suri R.M. et al. The effect of
tricuspid regurgitation and the right heart on survival
after transcatheter aortic valve replacement: Insights
from the PARTNER II Inoperable Cohort. Circ.
Cardiovasc. Interv. 2015; 8 (4): 002073. DOI: 10.1161/circinterventions.114.002073
About the authors
- Skopin Ivan Ivanovich, Dr. Med. Sc., Professor, Head of Department, Director of Institute of Coronary and Vascular Surgery; orcid.org/0000-0001-7411-202X;
-
Latyshev Mikhail Sergeevich, Resident Physician; orcid.org/0000-0003-1771-4264;
-
Vavilov Aleksandr Vladimirovich, Cardiovascular Surgeon; orcid.org/0000-0002-0488-5630;
-
Aleksanyan Garik Gagikovich, Junior Researcher; orcid.org/0000-0002-3385-1624
